Neurotech International Limited (NTI.AX)

0.0510 -0.0010 (-1.92%) At close: 04:10PM AEDT

Neurotech International Limited

145 Stirling Highway
Suite 5 CPC
Nedlands, WA 6009
Australia
61 8 9389 3130
https://www.neurotechinternational.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Alexandra Andrews	Chief Operating Officer	36k	N/A	N/A
Mr. Gerald Quigley	Director of Public Relations & Director	40.31k	N/A	N/A
Dr. Thomas Duthy M.B.A., Ph.D.	Executive Director	240k	N/A	N/A
Dr. Emanuela Russo	Chief Scientific Officer & Member of Scientific Advisory Board	N/A	N/A	N/A
Associate Prof. Carolyn Ellaway	Chief Medical Officer	N/A	N/A	N/A
Mr. Peter James Lawrence Griffiths B.Sc.	Chief Executive Officer of AAT Research Ltd	N/A	N/A	1964
Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG	Company Secretary	N/A	N/A	N/A
Ms. Alessandra Gauvin	Joint Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxation in autistic children exhibiting elevated delta band brain activity. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary NTI/Dolce cannabis strains. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia.

Corporate governance

Neurotech International Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.